Rezolute, Inc. (RZLT)
NASDAQ: RZLT · Real-Time Price · USD
3.290
+0.010 (0.30%)
At close: Feb 20, 2026, 4:00 PM EST
3.360
+0.070 (2.13%)
After-hours: Feb 20, 2026, 7:29 PM EST
Rezolute Employees
Rezolute had 75 employees as of December 31, 2025. The number of employees increased by 11 or 17.19% compared to the same quarter last year.
Employees
75
Change
11
Growth
17.19%
Revenue / Employee
n/a
Profits / Employee
-$1,123,040
Market Cap
341.74M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 75 | 11 | 17.19% |
| Sep 30, 2025 | 75 | 57 | 316.67% |
| Jun 30, 2025 | 71 | 12 | 20.34% |
| Mar 31, 2025 | 68 | 13 | 23.64% |
| Dec 31, 2024 | 64 | 7 | 12.28% |
| Sep 30, 2024 | 18 | -32 | -64.00% |
| Jun 30, 2024 | 59 | 8 | 15.69% |
| Mar 31, 2024 | 55 | 8 | 17.02% |
| Dec 31, 2023 | 57 | 9 | 18.75% |
| Sep 30, 2023 | 50 | 8 | 19.05% |
| Jun 30, 2023 | 51 | 9 | 21.43% |
| Mar 31, 2023 | 47 | 5 | 11.90% |
| Dec 31, 2022 | 48 | - | - |
| Jun 30, 2022 | 42 | 16 | 61.54% |
| Jun 30, 2021 | 26 | 3 | 13.04% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 533 |
| Puma Biotechnology | 172 |
| Nautilus Biotechnology | 124 |
| Foghorn Therapeutics | 112 |
| Aura Biosciences | 109 |
| Aclaris Therapeutics | 64 |
| Atea Pharmaceuticals | 56 |
| Immuneering | 54 |
RZLT News
- 2 days ago - RZLT INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - GlobeNewsWire
- 3 days ago - INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - Newsfile Corp
- 8 days ago - INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - PRNewsWire
- 9 days ago - Rezolute Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 11 days ago - SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - Newsfile Corp
- 12 days ago - Rezolute, Inc. (RZLT) Shares Tank 90% Amid Lead Asset Trial Failure -- Hagens Berman Investigating - GlobeNewsWire
- 16 days ago - SHAREHOLDER INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - Newsfile Corp
- 17 days ago - Rezolute to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 - GlobeNewsWire